82
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development and Validation of a Nomogram for Predicting 28-Day Mortality on Admission in Elderly Patients with Severe Community-Acquired Pneumonia

, , ORCID Icon, , , & show all
Pages 4149-4158 | Published online: 21 Jul 2022

References

  • Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677–686. doi:10.1001/jama.2015.88
  • Lee JS, Giesler DL, Gellad WF, et al. Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review. JAMA. 2016;315(6):593–602. doi:10.1001/jama.2016.0115
  • Kelly E, macredmond RE, Cullen G, et al. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia? Respirology. 2009;14(2):210–216. doi:10.1111/j.1440-1843.2008.01423.x
  • Cunha BA. Pneumonia in the elderly. Clin Microbiol Infect. 2001;7(11):581–588. doi:10.1046/j.1198-743x.2001.00328.x
  • Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi:10.1164/rccm.201908-1581ST
  • Gutiérrez F, Masiá M. Improving outcomes of elderly patients with community-acquired pneumonia. Drugs Aging. 2008;25(7):585–610. doi:10.2165/00002512-200825070-00005
  • Cilloniz C, Ceccato A, San Jose A, et al. Clinical management of community acquired pneumonia in the elderly patient. Expert Rev Respir Med. 2016;10(11):1211–1220. doi:10.1080/17476348.2016.1240037
  • Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest. 2006;130(1):11–15. doi:10.1378/chest.130.1.11
  • Marrie TJ. Community-acquired pneumonia in the elderly. Clin Infect Dis. 2000;31(4):1066–1078. doi:10.1086/318124
  • Kothe H, Bauer T, Marre R, et al. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J. 2008;32(1):139–146. doi:10.1183/09031936.00092507
  • Ko FW, Lam RKY, Li TST, et al. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong. Intern Med J. 2005;35(11):661–667. doi:10.1111/j.1445-5994.2005.00956.x
  • Thiem U, Niklaus D, Sehlhoff B, et al. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Age Ageing. 2009;38(6):693–697. doi:10.1093/ageing/afp164
  • Han MZ, Huang B, Ni SL, et al. A validated prognostic nomogram for patients with newly diagnosed lower-grade gliomas in a large-scale Asian cohort. Neuro Oncol. 2020;22(5):729–731. doi:10.1093/neuonc/noaa027
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(2):S27–72. doi:10.1086/511159
  • Song Y, Yao C, Yao Y, et al. XueBiJing injection versus placebo for critically Ill patients with severe community-acquired pneumonia: a randomized controlled trial. Crit Care Med. 2019;47(9):e735–e743. doi:10.1097/CCM.0000000000003842
  • Song J-H, Oh WS, Kang C-I, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008;31(2):107–114. doi:10.1016/j.ijantimicag.2007.09.014
  • Man SY, Lee N, Ip M, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax. 2007;62(4):348–353. doi:10.1136/thx.2006.069740
  • Janesch P, Stulik L, Rouha H, et al. Age-related changes in the levels and kinetics of pulmonary cytokine and chemokine responses to Streptococcus pneumoniae in mouse pneumonia models. Cytokine. 2018;111:389–397. doi:10.1016/j.cyto.2018.09.012
  • Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22(11):1041–1050. doi:10.1111/j.1432-2277.2009.00927.x
  • Saldías Peñafiel F, O’Brien Solar A, Gederlini Gollerino A, et al. [Community-acquired pneumonia requiring hospitalization in immunocompetent elderly patients: clinical features, prognostic factors and treatment]. Arch Bronconeumol. 2003;39(8):333–340. Spanish. doi:10.1016/S0300-2896(03)75400-3
  • Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022
  • Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020;9(1):687–690. doi:10.1080/22221751.2020.1741327
  • Kawano N, Wada H, Uchiyama T, et al. Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure. Thromb J. 2020;18(1):2. doi:10.1186/s12959-020-0216-6
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi:10.1016/j.kint.2020.03.005
  • Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults. Clin J Am Soc Nephrol. 2015;10(9):1510–1518. doi:10.2215/CJN.02140215
  • Lim WS, Laing R, Boersma WG, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi:10.1136/thorax.58.5.377
  • Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med. 1991;115(6):428–436. doi:10.7326/0003-4819-115-6-428
  • Raz R, Dyachenko P, Levy Y, et al. A predictive model for the management of community-acquired pneumonia. Infection. 2003;31(1):3–8. doi:10.1007/s15010-002-2083-4
  • Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis. 2008;15(3):222–234. doi:10.1053/j.ackd.2008.04.003
  • Baek MS, Park S, Choi J-H, et al. Mortality and prognostic prediction in very elderly patients with severe pneumonia. J Intensive Care Med. 2020;35(12):1405–1410. doi:10.1177/0885066619826045
  • Chen JH, Chang -S-S, Liu JJ, et al. Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects. Thorax. 2010;65(11):971–977. doi:10.1136/thx.2009.129627